It has been a few months since my coverage of Booking Holdings (NASDAQ: BKNG ) with the analysis “this travel titan quietly prints cash.” I believe the title sums up my thesis at the time: a leading company in its sector, with very strong cashEquity Research Analyst with a broad career in the financial market, covered both Brazilian and global stocks. As a value investor, my analysis is primarily fundamental, focusing on identifying undervalued stocks with growth potential. Feel free to reach out for collab ...

Seeking Alpha is currently holding an Article Competition with the theme " Best GARP Idea ," and I think Marvell Technology, Inc. (NASDAQ: MRVL ) is a perfect fit. The company is undervalued compared toMy primary area of concentration will be on identifying companies of exceptional caliber, with a proven ability to reinvest capital for impressive returns. Targeting those with a market capitalization of less than $10 billion, affords ample opportunities for growth. The ideal scenario is for these companies t ...

Seeking Alpha is currently holding an Article Competition with the theme " Best GARP Idea ," and I think Marvell Technology, Inc. (NASDAQ: MRVL ) is a perfect fit. The company is undervalued compared toMy primary area of concentration will be on identifying companies of exceptional caliber, with a proven ability to reinvest capital for impressive returns. Targeting those with a market capitalization of less than $10 billion, affords ample opportunities for growth. The ideal scenario is for these companies t ...

For several reasons, I tend to be skeptical about IPOs. Generally, the valuation is not the best, and the track record is also quite limited, which makes it difficult to build a compelling case for the thesis. Despite this, it is undeniable that some IPOs work.Equity Research Analyst with a broad career in the financial market, covered both Brazilian and global stocks. As a value investor, my analysis is primarily fundamental, focusing on identifying undervalued stocks with growth potential. Feel free to re ...

Software is facing threats from generative AI, and this is showing in valuations. Twilio (NYSE: TWLO ) is a standout name that showed it can balance an acceleration in top-line growth with a push into GAAP profitability. Amidst a frothy market, the valuationJulian is the leader of the investing group Best Of Breed Growth Stocks where he only shares positions in stocks which have a large probability of delivering large alpha relative to the S&P 500. He also combines growth-oriented principles with strict val ...

Software is facing threats from generative AI, and this is showing in valuations. Twilio (NYSE: TWLO ) is a standout name that showed it can balance an acceleration in top-line growth with a push into GAAP profitability. Amidst a frothy market, the valuationJulian is the leader of the investing group Best Of Breed Growth Stocks where he only shares positions in stocks which have a large probability of delivering large alpha relative to the S&P 500. He also combines growth-oriented principles with strict val ...

I am always on the lookout for strongly undervalued stocks, in the dirt and under the rocks. Following me will allow you to read about little known, forgotten and underrated stocks, in any geography and sector.My name is Akim and I am a professional portfolio manager for investment funds.I live in beautiful Luxembourg and graduated from a business major, having studied in France, in the U.S. and in Russia.My articles are completely independent. I am since early 2022 a Popular Investor on the brokerage platf ...

投资策略 - 在极端市场不稳定时期 投资者需要在价值策略和增长投资之间做出选择 价值策略寻求折价股票 而增长投资关注增长潜力[1] - GARP策略是增长和价值投资原则的战略性混合 提供了一种混合策略 结合了两者的最佳特征 寻找略有低估且具有坚实可持续增长潜力的股票[3] - 沃伦·巴菲特的投资轨迹显示其从纯粹的价值投资者逐渐转向GARP投资者[2] GARP策略核心指标 - GARP投资优先考虑价格收益增长PEG比率 PEG比率定义为市盈率除以收益增长率 将股票的市盈率与未来收益增长率联系起来[5] - 单独的市盈率可以了解折价交易的股票 而PEG增加了增长元素 有助于识别具有坚实未来潜力的股票 较低的PEG比率 最好小于1 对GARP投资者更有利[6] - PEG比率存在一些缺点 例如未考虑增长率变化的情况 因此如果同时考虑其他相关参数 PEG投资可能更有回报[7] 筛选标准 - PEG比率低于行业中期水平 市盈率使用F1低于行业中期水平 Zacks排名为1强力买入或2买入 市值大于10亿美元[8] - 20天平均交易量大于5万股 确保股票易于交易 F1收益估计修订4周百分比变化大于5% 向上修正增加乐观情绪[9] - 价值评分小于或等于B 研究表明 价值风格评分为A或B的股票 与Zacks排名1 2或3持有结合 提供最佳上涨潜力[10] 成功案例股票 - Halozyme Therapeutics HALO 是一家生物制药公司 专注于开发和商业化针对肿瘤微环境的新型治疗方法 并许可其ENHANZE药物输送技术 用于皮下给药 具有Zacks排名1和价值评分B 折价PEG和市盈率 长期预期增长率为31%[11][12] - Phibro Animal Health PAHC 是一家全球多元化的动物健康和矿物营养公司 提供广泛的产品 用于家禽 猪 牛肉和奶牛以及水产养殖 具有Zacks排名2和价值评分B 折价PEG和市盈率 长期预期增长率为15%[13][14] - Leidos LDOS 是一家全球科学和技术领导者 服务于国防 情报 民用和健康市场 核心能力包括网络安全 数据分析 企业IT现代化 运营和物流等领域 具有Zacks排名2和价值评分B 折价PEG和市盈率 长期历史增长率为14.6%[15][16] - PDD Holdings Inc. PDD 是一家跨国商业集团 拥有并运营一系列业务 从在线营销服务和交易服务中受益 目前专注于将更多企业和人员带入数字经济 具有Zacks排名1和价值评分B 折价PEG和市盈率 长期预期增长率为9.7%[17][18] 策略有效性 - 近年来大幅上涨的几只股票证明了这种混合投资策略相对于纯粹价值投资和增长投资的压倒性成功[4] - 这些股票包括Halozyme Therapeutics HALO Phibro Animal Health PAHC Leidos LDOS 和PDD Holdings Inc. PDD[4]

行业与公司 * 行业涉及美国股票市场 特别是人工智能AI主题投资 以及成长型与价值型股票的风格比较[1] * 公司提及花旗研究Citi Research及其核心AI投资组合 包括美国合理价格AI指数CGRBAIRP和国际合理价格AI指数CGRBAIRX[2] 核心观点与论据 * AI主题作为美国市场主要的成长股组成部分 约占标普500指数市值的50%[1] * 自4月底以来 成长股继续领先大盘股指数 AI主题表现优于大盘[1] * 自7月中旬以来 AI主题投资波动性增加 但花旗的GARP（合理价格增长）叠加策略投资组合波动性小于更广泛的主题投资组合[2] * 在关税暂停后的时期 国际AI GARP投资组合的实际上涨波动率介于纳斯达克100指数和标普500指数之间 但实现了强劲的超额收益[3] * 国际AI篮子在此期间的表现在很大程度上与美国版本一致 但因其结合了发达市场和新兴市场的风险敞口而存在折价 近期该篮子实际上已创出新高 而更广泛的AI篮子和纳斯达克100指数则较峰值低1-2%[4] * 估值叠加策略在情绪驱动的反弹中可能滞后 但有助于管理回报波动性[5] * 市场 broadening trade（行情扩散）不仅在美国市场内部（价值vs成长风格 中小盘vs大盘）很明显 在地理区域的主题内部也很明显[5] * 继续看好AI作为一个有吸引力的主题 但倾向于为核心头寸采用GARP叠加策略 并喜欢将新资金投向国际AI 尤其是其投资组合内的机会[6] * 非AI主题（无AI重叠的金融科技和可穿戴技术）以及特定行业组别（金融、公用事业）是完善核心投资组合或构建价值侧翼的有吸引力的方式[6] 其他重要内容 * 报告包含分析师认证、重要披露和研究分析师关联关系信息 指出花旗全球市场公司及其关联公司可能与研究报告所涵盖的公司有业务往来 可能存在利益冲突[7] * 报告包含了花旗研究股票评级分布数据（截至2025年7月1日） 全球基本面覆盖股票评级为买入58% 持有32% 卖出9%[16] * 报告包含了投资评级定义（买入、中性、卖出）及其基于预期总回报ETR的标准[17] * 报告包含了催化剂观察/短期观点STV评级披露[19] * 报告包含了针对多个国家或地区投资者的特定披露和法律声明[30][32][33][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58]

投资评级与分析师背景 - 对日月光投控给予买入评级 [1] - 分析师采用GARP投资策略 偏好具有积极增长前景的公司 [1] - 投资哲学强调长期纪律性 持续超额收益和风险控制 [1] 公司业务前景 - 公司预计在未来1-2年内实现高盈利水平 [1] - 增长前景被认定为积极型 [1] 分析师持仓披露 - 分析师当前未持有该公司股票或衍生品头寸 [1] - 可能在未来72小时内建立多头头寸或认购期权 [1] - 分析内容基于独立观点 未受公司补偿 [1] 内容发布平台说明 - 分析内容由第三方作者提供 包括专业和个人投资者 [2] - 平台强调历史表现不保证未来结果 [2] - 平台不持有证券交易牌照或投资顾问资质 [2]